FB
REGN icon

Fulton Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Fulton Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
2,081
-159
-7% -$108K 0.04% 287
2026
Q1 		$1.73M Sell
2,240
-65
-3% -$49.8K 0.06% 214
2025
Q4 		$1.78M Sell
2,305
-261
-10% -$177K 0.06% 204
2025
Q3 		$1.44M Sell
2,566
-12
-0.5% -$6.79K 0.05% 234
2025
Q2 		$1.35M Sell
2,578
-229
-8% -$128K 0.05% 238
2025
Q1 		$1.78M Sell
2,807
-258
-8% -$177K 0.07% 194
2024
Q4 		$2.18M Sell
3,065
-307
-9% -$258K 0.08% 173
2024
Q3 		$3.54M Sell
3,372
-550
-14% -$612K 0.14% 113
2024
Q2 		$4.12M Buy
3,922
+58
+2% +$56.2K 0.17% 96
2024
Q1 		$3.72M Buy
3,864
+111
+3% +$106K 0.15% 107
2023
Q4 		$3.3M Sell
3,753
-205
-5% -$169K 0.15% 113
2023
Q3 		$3.26M Buy
3,958
+95
+2% +$74.7K 0.16% 107
2023
Q2 		$2.78M Sell
3,863
-393
-9% -$303K 0.14% 127
2023
Q1 		$3.5M Buy
4,256
+253
+6% +$191K 0.18% 101
2022
Q4 		$2.89M Buy
4,003
+318
+9% +$235K 0.16% 119
2022
Q3 		$2.54M Buy
3,685
+518
+16% +$326K 0.15% 125
2022
Q2 		$1.87M Buy
3,167
+26
+0.8% +$16.9K 0.1% 156
2022
Q1 		$2.19M Buy
3,141
+96
+3% +$60.7K 0.1% 152
2021
Q4 		$1.92M Buy
3,045
+277
+10% +$170K 0.08% 164
2021
Q3 		$1.68M Buy
2,768
+82
+3% +$50.9K 0.08% 171
2021
Q2 		$1.5M Buy
+2,686
New +$1.36M 0.07% 182

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fulton Bank's REGN Position: Q2 2026 in Review

Fulton Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 7.1% in Q2 2026, selling an estimated $108K and leaving 2,081 shares worth $1.3M. The position accounts for 0.04% of the portfolio, ranked #287.

Fulton Bank first reported a position in REGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.12M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Fulton Bank held 2,081 shares of Regeneron Pharmaceuticals worth $1.3M as of Q2 2026.
  • Fulton Bank sold 159 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $108K.
  • Regeneron Pharmaceuticals made up 0.04% of Fulton Bank's portfolio in Q2 2026, its #287 holding.
  • Fulton Bank first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Fulton Bank's Regeneron Pharmaceuticals position peaked at $4.12M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.